ArticleProblemy endokrinologii2026

[Safety Management of Incretin-Based Obesity Therapy: Expert Consensus on the Use of Semaglutide and Tirzepatide].

E A Troshina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.